文献速递头颈神经MR

治疗前表观扩散系数(ADC)对接受放化疗的头颈部鳞状细胞癌的预测价值

Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma.
PubMed 文献 · Radiol Med · 2017-02-10

研究纳入57例接受放化疗的头颈部鳞癌患者,治疗前测量ADC最小值、最大值和平均值。局部控制组治疗前ADC平均值和最小值低于复发/持续病灶组。ROC分析显示平均ADC诊断敏感度50%、特异度84.8%,最小ADC敏感度42.9%、特异度87.9%。

要点

  • 局部控制组治疗前ADC平均值和最小值低于复发/持续病灶组。
  • 平均ADC的ROC分析敏感度50%、特异度84.8%。
  • 最小ADC的ROC分析敏感度42.9%、特异度87.9%。

核心结论

  • 局部控制患者治疗前ADC值低于病灶持续或复发患者。

研究设计与样本

  • 研究纳入57例头颈部鳞癌患者,治疗前采集ADC图并计算最小值、最大值和平均值ADC。

诊断标准与关键数值

  • 局部控制组治疗前平均ADC 0.83 ± 0.02 × 10-3 mm2/s,持续/复发组0.94 ± 0.05 × 10-3 mm2/s。
  • 局部控制组治疗前最小ADC 0.59 ± 0.02 × 10-3 mm2/s,持续/复发组0.70 ± 0.05 × 10-3 mm2/s。
  • 平均ADC的ROC分析:敏感度50%,特异度84.8%。
  • 最小ADC的ROC分析:敏感度42.9%,特异度87.9%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed at evaluating the role of "baseline" apparent diffusion coefficent (ADC), in patients affected by head and neck cancer treated with radio-chemotherapy, as a potential marker of response to therapy.

METHODS: Fifty-seven patients underwent pretreatment ADC maps. Minimum, maximum, and medium ADC were computed. Age, dose, treatment time, and ADC values were compared between the two groups (Group 1: local control; Group 2: relapse/persistence of disease) using the Student t test two-tailed unpaired. Two-tailed Fischer exact test was used to compare T stage, N stage, grading and type of treatment between two groups. We have analyzed the receiver operating characteristic (ROC) of statistically significant variables.

RESULTS: In patients with local control, values of pre-treatment medium and minimum ADC were lower than ADC values of patients with persistent or recurrent disease, with values, respectively, of 0.83 ± 0.02 × 10-3 mm2/s and 0.59 ± 0.02 × 10-3 mm2/s (vs 0.94 ± 0.05 × 10-3 mm2/s and 0.70 ± 0.05 × 10-3 mm2/s). ROC curve analysis displayed statistical significance as regarding the medium ADC value, showing a sensitivity of 50% and a specificity of 84.8%. ROC analysis of the values minimum ADC showed a sensitivity of 42.9% and specificity of 87.9%.

CONCLUSION: The value of the ADC pre-treatment of patients with local control of the disease is lower than that of patients with persistent disease or recurrence.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Lombardi M, Cascone T, Guenzi E, et al. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma. Radiol Med. 2017. PMID: 28188603. doi:10.1007/s11547-017-0733-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。